Cancer Incidence and Mortality among Non-Hispanics, New York City, 2015-2019

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 33841.4 470.9 468.6-473.2 16295.8 508.0 504.4-511.6 17545.6 449.4 446.3-452.4 9741.2 130.8 129.7-132.0 4712.0 151.0 149.1-153.0 5029.2 117.7 116.2-119.2
Oral cavity and pharynx 753.0 10.5 10.2-10.9 488.8 15.2 14.6-15.8 264.2 6.7 6.3-7.1 156.6 2.1 2.0-2.3 108.0 3.4 3.1-3.7 48.6 1.1 1.0-1.3
Esophagus 256.0 3.4 3.2-3.6 181.8 5.6 5.2-6.0 74.2 1.7 1.6-1.9 175.0 2.3 2.2-2.5 126.0 3.9 3.6-4.2 49.0 1.1 1.0-1.3
Stomach 755.0 10.4 10.1-10.7 438.0 13.8 13.2-14.4 317.0 7.8 7.4-8.2 327.2 4.4 4.2-4.7 194.6 6.3 5.9-6.7 132.6 3.1 2.8-3.3
Colorectal 2792.2 38.8 38.1-39.4 1424.2 45.2 44.1-46.2 1368.0 33.9 33.0-34.7 923.0 12.4 12.0-12.8 446.6 14.4 13.8-15.0 476.4 10.9 10.5-11.4
Colon excluding rectum 1964.0 27.1 26.6-27.7 965.4 30.7 29.8-31.6 998.6 24.4 23.7-25.1 755.0 10.1 9.8-10.4 355.2 11.4 10.9-12.0 399.8 9.1 8.7-9.6
Rectum & rectosigmoid 828.2 11.7 11.3-12.0 458.8 14.4 13.8-15.1 369.4 9.5 9.0-9.9 168.0 2.3 2.1-2.5 91.4 3.0 2.7-3.3 76.6 1.8 1.6-2.0
Liver / intrahepatic bile duct 761.6 10.2 9.9-10.5 537.2 16.2 15.6-16.8 224.4 5.4 5.0-5.7 466.8 6.2 6.0-6.5 310.4 9.5 9.0-10.0 156.4 3.6 3.4-3.9
Pancreas 1044.2 14.0 13.7-14.4 499.0 15.7 15.1-16.3 545.2 12.7 12.2-13.2 790.4 10.5 10.2-10.8 375.8 11.8 11.3-12.4 414.6 9.4 9.0-9.8
Larynx 197.8 2.7 2.5-2.8 159.6 4.9 4.6-5.3 38.2 0.9 0.8-1.1 57.6 0.8 0.7-0.9 45.0 1.4 1.2-1.6 12.6 0.3 0.2-0.4
Lung and bronchus 3732.0 50.3 49.6-51.0 1848.4 58.0 56.8-59.3 1883.6 44.8 43.9-45.7 1962.4 26.1 25.6-26.7 1028.4 32.6 31.7-33.5 934.0 21.5 20.8-22.1
Melanoma of the skin 884.4 12.4 12.1-12.8 494.4 16.0 15.3-16.6 390.0 10.0 9.5-10.5 77.4 1.1 1.0-1.2 45.8 1.5 1.3-1.7 31.6 0.8 0.6-0.9
Female breast             5201.6 138.1 136.4-139.9             825.4 20.0 19.4-20.7
Cervix uteri             315.4 9.0 8.5-9.4             85.0 2.2 2.0-2.5
Corpus uterus and NOS             1364.6 33.8 33.0-34.6             320.0 7.5 7.1-7.9
Ovary             460.2 12.1 11.6-12.7             281.2 6.8 6.4-7.2
Prostate       4463.0 131.8 130.1-133.6             554.4 18.3 17.6-19.0      
Testis       167.6 5.6 5.2-6.0             4.0 0.1 0.1-0.2      
Urinary bladder (incl. in situ) 1365.4 18.4 18.0-18.9 1017.4 32.7 31.8-33.6 348.0 8.1 7.7-8.5 262.4 3.4 3.2-3.6 180.2 6.0 5.6-6.4 82.2 1.8 1.6-1.9
Kidney and renal pelvis 1115.2 15.6 15.2-16.0 719.6 22.4 21.7-23.2 395.6 10.0 9.6-10.5 182.8 2.4 2.3-2.6 123.0 3.9 3.6-4.2 59.8 1.3 1.2-1.5
Brain and other central nervous system 411.2 6.2 6.0-6.5 226.4 7.5 7.0-7.9 184.8 5.2 4.9-5.6 223.6 3.2 3.0-3.4 121.4 3.9 3.6-4.3 102.2 2.6 2.4-2.9
Thyroid 1446.8 22.3 21.8-22.8 364.8 11.9 11.3-12.5 1082.0 31.7 30.9-32.6 39.0 0.5 0.4-0.6 15.4 0.5 0.4-0.6 23.6 0.5 0.4-0.6
Hodgkin lymphoma 196.2 3.1 2.9-3.3 105.6 3.6 3.3-3.9 90.6 2.7 2.5-3.0 16.8 0.2 0.2-0.3 9.6 0.3 0.2-0.4 7.2 0.2 0.1-0.3
Non-Hodgkin lymphomas 1462.0 20.7 20.2-21.2 778.6 25.1 24.3-25.9 683.4 17.3 16.7-17.9 321.0 4.3 4.1-4.6 176.8 5.8 5.4-6.2 144.2 3.3 3.1-3.6
Myeloma 668.2 9.1 8.8-9.4 341.2 10.7 10.2-11.2 327.0 7.9 7.5-8.3 217.2 2.9 2.7-3.1 111.4 3.5 3.2-3.9 105.8 2.4 2.2-2.6
Leukemias 1009.6 14.4 14.0-14.8 560.6 18.3 17.6-19.0 449.0 11.4 10.9-11.9 377.2 5.2 5.0-5.4 201.4 6.7 6.3-7.1 175.8 4.2 3.9-4.5

Notes

  • Incidence data are provisional, November 2021.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.